Buy Tagrisso (Osimertinib) Online For Sale

$5,460.00

DISEASE INDICATIONS: Lung Cancer

MANUFACTURER: AstraZeneca AB

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Medsafe (NZ)

Tagrisso is a medication used to treat non-small cell lung cancer with EGFR T790M mutation. It inhibits the activity of the EGFR protein, leading to cancer cell death.

Compare

Description

Tagrisso (osimertinib) is a medication used to treat non-small cell lung cancer (NSCLC) that has a specific genetic mutation known as epidermal growth factor receptor (EGFR) T790M mutation. This drug blocks the activity of the EGFR protein and inhibits tumor cell growth.

Storage Conditions:
Tagrisso should be stored at room temperature and protected from light and moisture. Keep it away from children and pets.

Mechanism of Action:
Tagrisso selectively binds to the mutated EGFR protein T790M. The drug then inhibits the activity of the protein, which stops the growth of cancer cells and leads to their death.

How to Use:
Tagrisso is taken orally once daily as directed by the doctor. It can be taken with or without food. The medication should not be crushed, broken or chewed. Patients should not exceed the recommended dose as it may lead to serious side effects.

Precautions:
Before taking Tagrisso, patients should inform their doctor of any other medications or supplements they are taking, as these may interact with the drug. Patients should also inform their doctor of any medical conditions they have, including liver or kidney disease and any allergies. Pregnant and breastfeeding women should avoid taking Tagrisso.

Drug Interactions:
Tagrisso may interact with other medications, including antifungal drugs, antibiotics, blood thinners, and some anticonvulsants. Patients should discuss all medications and supplements they are taking with their doctor.

Contraindications:
Tagrisso should not be taken by patients who are allergic to osimertinib or any of the drug’s components. Patients should also not take Tagrisso if they are pregnant, breastfeeding, or have severe liver or kidney disease.

Overdose:
In the case of an overdose, patients should seek emergency medical attention immediately. Symptoms of an overdose may include nausea, vomiting, diarrhea, liver problems, and electrolyte imbalances.

Adverse Reactions:
The side effects of Tagrisso may include diarrhea, nausea, vomiting, decreased appetite, rash, and dry skin. More serious side effects may include interstitial lung disease, heart problems, and eye problems. Patients should inform their doctor immediately if they experience any unusual symptoms while taking Tagrisso.

Additional information

Package

30 tablets of 80 mg

Reviews

There are no reviews yet.

Be the first to review “Buy Tagrisso (Osimertinib) Online For Sale”

Your email address will not be published. Required fields are marked *